Revision history of "Development of new hepatoprotective and pro-regenerative molecules based on fibroblast growth factor 15/19 (FGF15/19) and anfirreguline (AR)." (Q3198301)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 11:1411:14, 8 October 2024DG Regio talk contribs 78,376 bytes +2 Changed label, description and/or aliases in pt
  • curprev 11:1411:14, 8 October 2024DG Regio talk contribs 78,374 bytes 0 Set a claim value: summary (P836): Atualmente, não existem estratégias farmacológicas eficazes que preservem a viabilidade do parênquima hepático e estimulem a sua regeneração. Esta deficiência é evidente em situações clínicas agudas, como a cirurgia de ressecção hepática para tumores primários e metástases, transplante de doador vivo ou insuficiência hepática aguda induzida por toxinas, vírus ou álcool, condições que se tornam mais agudas no fígado gorduroso. Uma fonte de potenciais...

20 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 09:1209:12, 18 August 2022DG Regio talk contribs 77,102 bytes +53,188 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

13 October 2021

  • curprev 01:3301:33, 13 October 2021DG Regio talk contribs 12,836 bytes +201 Changed label, description and/or aliases in en: translated_label
  • curprev 01:3301:33, 13 October 2021DG Regio talk contribs 12,635 bytes +2,386 Created claim: summary (P836): There are currently no effective pharmacological strategies that preserve the viability of the liver parenchyma and stimulate its regeneration. This deficiency is evident in acute clinical situations such as hepatic resection surgery for primary tumors and metastases, live donor transplantation or acute liver failure induced by toxins, viruses or alcohol, conditions that become more acute in the fatty liver. A source of potential hepatoprotectiv...

11 October 2021

10 October 2021

8 October 2021